Riga

Riga is rapidly emerging as a premier Baltic hub for the life sciences ecosystem.

The city is internationally recognized for its pharmaceutical industry leadership, anchored by global players like Grindeks and Olainfarm, which specialize in active pharmaceutical ingredients (APIs) and final dosage forms.

Significant advancements in biotechnology are driven by the Latvian Biomedical Research and Study Centre (BMC), a cornerstone for genomics, precision medicine and large-scale biobanking.

Riga’s academic research landscape is further strengthened by the Latvian Institute of Organic Synthesis (LIOS), a world-class center for drug discovery and organic chemistry.

The region’s burgeoning medical device sector features pioneers like Biosan and CastPrint, specializing in laboratory equipment and 3D-printed orthopedic solutions.

Digital health and healthtech startups are revolutionizing patient engagement and clinical trial recruitment through AI-driven data analytics.

The ongoing merger of top research institutions into the Baltics' largest life sciences center marks a new era for translational medicine in the capital.

Riga also excels in biomedicine through innovative ventures like Cellbox Labs, which develops sophisticated organ-on-a-chip technologies for in vitro testing.

Supported by national initiatives like BioPhoT, the ecosystem fosters a seamless bridge between scientific excellence and commercialization.

Ultimately, Riga offers a competitive, EU-compliant environment for international collaboration, investment and high-impact scientific breakthroughs.